Delivery Order SPE2DB22D1106-SPE2DB25FDHP9

Award Date 10/18/24
Potential Completion Date 10/21/24
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,771.40 firm-fixed price delivery order is for the drug Trulicity, a medication used for diabetes management. The contract has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The $2,951.88 firm fixed-price delivery order is for the supply of the drug Trulicity, a medication used to treat type 2 diabetes. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,224.04 firm fixed-price delivery order is for the drug Trulicity, a treatment for diabetes, with a completion date of May 21, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a $8,054.88 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the specialty medication Trulicity, a diabetes treatment product. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical and medical supplies for military healthcare programs. The...
This federal contract award, valued at $1,380.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Trulicity, a diabetes medication, with a performance period through May 2025. This contract is not set aside and represents an individual delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,054.94 delivery order is for the supply of Trulicity, a medication used to manage diabetes, and represents a portion of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Amerisourcebergen and the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,262.87 firm fixed-price delivery order is for the supply of the drug Trulicity, a medication used to manage diabetes. The contract has an ultimate completion date of August 3, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,484.88 firm fixed-price delivery order covers the supply of the drug Trulicity, a medication used for the treatment of diabetes. The contract has an ultimate completion date of October 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,306.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Trulicity, a medication used for diabetes management. The contract has an ultimate completion date of October 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $17,026.11 firm-fixed-price delivery order is for the supply of Trulicity, a diabetes medication, with a period of performance through May 2025. The contract is not set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDHP9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,111.86 delivery order is for the supply of Trulicity, a drug used to treat diabetes, and does not have a set-aside designation.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 1/17/25, 9:11 AM